| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |